Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity

Abstract : Senescence is activated in response to chemotherapy to prevent the propagation of cancer cells. In transformed cells, recent studies have shown that this response is not always definitive and that persistent populations can use senescence as an adaptive pathway to restart proliferation and become more aggressive. Here we discuss the results showing that an incomplete and heterogeneous senes-cence response plays a key role in chemotherapy resistance. Surviving to successive chemotherapy regimens, chronically existing senescent cells can create a survival niche through paracrine cooperations with neighboring cells. This favors chemotherapy escape of premalignant clones but might also allow the survival of adjacent clones presenting a lower fitness. A better characterization of senescence heterogeneity in transformed cells is therefore necessary. This will help us to understand this incomplete response to therapy and how it could generate clones with increased tumor capacity leading to disease relapse. ARTICLE HISTORY
Document type :
Journal articles
Complete list of metadatas

Cited literature [34 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02281354
Contributor : Elizabeth Bernardo <>
Submitted on : Monday, September 9, 2019 - 9:59:30 AM
Last modification on : Tuesday, September 10, 2019 - 1:23:33 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Jordan Guillon, Coralie Petit, Bertrand Toutain, Catherine Guette, Eric Lelievre, et al.. Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity. Cell Cycle, Taylor & Francis, 2019, 18 (19), pp.2385-2397. ⟨10.1080/15384101.2019.1652047⟩. ⟨inserm-02281354⟩

Share

Metrics

Record views

53